海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer
- Gastric Caner
- China
- 2014-03-08
Not Recruiting
- Alternative donor hematopoietic stem cell transplantation as first line therapy for children with severe aplastic anemia
- aplastic anemia
- China
- 2014-03-07
Recruiting
- Alternative donor hematopoietic stem cell transplantation as first line therapy for patient with severe aplastic anemia: a multi-centre prospective study
- aplastic anemia
- China
- 2014-03-01
Not Recruiting
- Effects of Progressive Muscle Relaxation as part of a Worksite Health Promotion Program to Alleviate Stress in the Automotive Assembly Line.
- occupational stress.
- Malaysia
- 2014-02-28
Not recruiting
- Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
- Metastatic Colorectal Cancer
- Argentina, Brazil, India, Peru, Russian Federation, Spain, Ukraine
- 2014-02-14
Recruiting
- FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer
- Metastatic Colorectal Cancer
- China
- 2014-02-08
Not recruiting
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2014-01-19
Recruiting
- Randomized study of first-line pemetrexed (Pe) plus platinum (P) followed by second-line docetaxel (D) versus first-line DP followed by second-line Pe in advanced non-small cell lung cancer
- Lung cancer
- China
- 2014-01-17
Recruiting
- mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer
- Metastatic Pancreatic Cancer
- China
- 2014-01-01
Not recruiting
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
- Endometrial Cancer;Endometrial Cancer;Endometrial Cancer;Endometrial Cancer
- Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Czech Republic, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom, United States
- 2013-01-09
Not recruiting
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
- Colorectal Cancer Metastatic
- Austria, Belgium, Canada, China, Czech Republic, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Singapore, Spain, United Kingdom, United States
- 2011-11-24
Not Recruiting
- Short-term efficacy fety of high dose nimotuzumab in combination with concurrent chemoradiationas first-line treatment for patientswith local advanced esophageal squamous cell carcinoma : A Multicenter Study.
- esophageal carcinoma
- China
- 2015-09-14
Not Recruiting
- Apatinib as Maintenance Therapy After First-line Chemotherapy (DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
- Gastric Cancer
- China
- 2015-08-25
Recruiting
- A CLINICAL STUDY ON DIAGNOSTIC METHODOLOGY SYMPTOMATOLOGY AND LINE OF TREATMENT FOR THE DISEASES OF WOMEN DURING REPRODUCTIVE PERIOD
- PATIENTS WITH JOINTPAIN HEADACHE DEPRESSION WEIGHT LOSSS EXCESSIVE THIRST VOMITTING
- India
- 2015-08-18
Authorised
- BI 1361849 (CV9202) + afatinib compared with placebo + afatinib in first-line NSCLC harbouring common EGFR mutations
- Advanced non-small cell lung cancer (adenocarcinoma) stage IV. MedDRA version: 18.1 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 18.1 Level: LLT Classification code 10025055 Term: Lung cancer non-small cell stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 18.1 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Canada, Denmark, France, Germany, Korea, Republic of, Poland, Portugal, Singapore, Spain, Taiwan, Thailand, United States
- 2015-08-17
Recruiting
- Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
- Gastric Cancer;Gastric Cancer;Gastric Cancer;Gastric Cancer
- China
- 2015-07-26
Recruiting
- Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma
- Advanced Lung Squamous Carcinoma
- China
- 2015-07-17
Recruiting
- Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer
- Gastric Cancer
- China
- 2015-07-13
Recruiting
- Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer
- Gastric Cancer;Gastroesophageal Junction Cancer
- Korea, Republic of
- 2015-07-08
Not recruiting
- Phase II Trial of HM61713 for the Treatment of =2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
- Non Small Cell Lung Cancer;Non Small Cell Lung Cancer;Non Small Cell Lung Cancer
- Australia, Canada, Germany, Italy, Korea, Republic of, Malaysia, Philippines, Spain, Taiwan, United States
- 2015-06-22
